Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy

David Zemánek1, Pavol Tomasov, Stanislava Homolová

  • 1Department of Cardiology, University Hospital Motol, First and Second Medical School of Charles University, V Uvalu 84, 150 21 Prague, Czech Republic. zejada@seznam.cz

Insights

The isosorbide dinitrate (ISDN) spray test effectively detects left ventricular outflow tract (LVOT) obstruction in hypertrophic cardiomyopathy (HCM) patients. Optimal detection occurs 5-10 minutes post-administration, with negative tests warranting further exercise echocardiography.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Pharmacological Stress Testing

Background:

  • Hypertrophic cardiomyopathy (HCM) frequently presents with left ventricular outflow tract (LVOT) obstruction.
  • Provocative testing is crucial for routine HCM evaluation to assess obstruction.
  • Sublingual isosorbide dinitrate (ISDN) spray is a potential agent for obstruction provocation.

Purpose of the Study:

  • To evaluate the diagnostic utility of sublingual ISDN spray for detecting LVOT obstruction in HCM patients.
  • To determine the optimal timing for LVOT gradient measurement after ISDN administration.
  • To compare the efficacy of ISDN testing with rest and exercise echocardiography.

Main Methods:

  • Prospective analysis of 77 consecutive HCM patients.
  • Measurement of LVOT gradient at rest, after ISDN spray (2.5 mg at 2, 5, and 10 minutes), and during exercise echocardiography.
  • Definition of obstruction as a gradient ≥ 30 mmHg.

Main Results:

  • Resting LVOT obstruction was present in 19% of patients.
  • ISDN testing revealed obstruction in 55% of patients, with peak detection at 5-10 minutes.
  • Exercise echocardiography identified obstruction in 71% of patients.
  • ISDN test demonstrated 76% sensitivity and 100% specificity compared to exercise testing.

Conclusions:

  • Sublingual ISDN spray is a reliable screening tool for HCM-related LVOT obstruction.
  • LVOT gradient measurement should be performed 5-10 minutes after ISDN spray application.
  • Patients with a negative ISDN test result should proceed to exercise echocardiography for definitive assessment.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...